Your browser doesn't support javascript.
loading
Optimal predictive probability designs for randomized biomarker-guided oncology trials.
Zabor, Emily C; Kaizer, Alexander M; Pennell, Nathan A; Hobbs, Brian P.
Affiliation
  • Zabor EC; Lerner Research Institute & Taussig Cancer Institute, Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, United States.
  • Kaizer AM; Colorado School of Public Health, Department of Biostatistics and Informatics, University of Colorado, Aurora, CO, United States.
  • Pennell NA; Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, United States.
  • Hobbs BP; Department of Population Health, University of Texas-Austin, Austin, TX, United States.
Front Oncol ; 12: 955056, 2022.
Article in En | MEDLINE | ID: mdl-36561534
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies / Qualitative_research / Risk_factors_studies Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies / Qualitative_research / Risk_factors_studies Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: Country of publication: